Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Nanlin Li"'
Autor:
Dongdong Xu, Jiang Wu, Jing Yu, Yuqing Yang, Xinxin Wen, Jixin Yang, Hongliang Wei, Xiaolong Xu, Yike Li, Liu Yang, Lei Wang, Yijia Wang, Wen Ma, Nanlin Li
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundHER2-positive molecular breast cancer subtypes are characterized by high aggressiveness and malignancy, and their metastasis and mortality rates are among the highest of all types of breast cancer. The use of anti-HER2-targeted agents in ne
Externí odkaz:
https://doaj.org/article/4f84a0ccd43249b28bf0a3efabec129d
Publikováno v:
Cancer Control, Vol 30 (2023)
Breast cancer has surpassed lung cancer as the most common cause of cancer deaths, worldwide. Early breast cancers are treatment sensitive and patients under standardized treatment have prolonged. Breast cancer treatment has significantly evolved fro
Externí odkaz:
https://doaj.org/article/7e610263ecda41969ab8aea0f4099cd9
Autor:
Jiao Yang, Bing Zhao, Xiaoling Ling, Donghui Li, Jiuda Zhao, Yonggang Lv, Guangxi Wang, Xinlan Liu, Nanlin Li, Jin Yang
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background Real-world data of Palbociclib are insufficient in China. This study aimed to investigate the treatment pattern and real-world outcomes in hormone receptor positive and human epidermal growth factor 2 receptor negative (HR+/HER2-)
Externí odkaz:
https://doaj.org/article/c3ffeebd4cbb4a33b98cfe55cbc2b50f
COVID-induced 3 weeks’ treatment delay may exacerbate breast cancer patient’s psychological symptoms
Publikováno v:
Frontiers in Psychology, Vol 13 (2022)
The delayed access to cancer treatment due to the outbreak of COVID-19 pandemic posed a unique challenge to breast cancer patients and caused a significant level of mental distress among them. In the current research, we examined the psychological im
Externí odkaz:
https://doaj.org/article/dde4d6e3de6b4aebb102bc49e46e31cb
Autor:
Fanfan Li, Qian Ju, Cong Gao, Jingjing Li, Xiaolei Wang, Min Yan, Liying Zhang, Meiling Huang, Qihe Long, Xiangting Jin, Nanlin Li
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveTo explore the correlation between HER-2 status and pathological complete response (pCR) in HER-2-positive breast cancer after dual anti-HER-2 neoadjuvant therapy with trastuzumab and pertuzumab.MethodsA total of 57 HER-2-positive breast can
Externí odkaz:
https://doaj.org/article/f85291b8604d4de9a349c8d201d80d49
Autor:
Jiang Wu, Jing Yu, Yuqing Yang, Xinxin Wen, Jixin Yang, Hongliang Wei, Xiaolong Xu, Yike Li, Liu Yang, Dongdong Xu, Lei Wang, Yijia Wang, Wen Ma, Nanlin Li
Publikováno v:
Cancer Research. 83:P3-07
Background: Despite that dual anti-HER2 therapy (Trastuzumab and Pertuzumab, TP) is one of the commonly used regimens for neoadjuvant treatment of HER2-positive breast cancer, previous studies showed that its pCR rate rarely exceeds 63%. Additionally
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::782a25d103a5fd2e69706a98e98af281
https://doi.org/10.1158/1538-7445.sabcs22-p3-07-25
https://doi.org/10.1158/1538-7445.sabcs22-p3-07-25
Publikováno v:
Translational Cancer Research. 12:247-256
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e47fb74e3110c95136d63ed66a880913
https://doi.org/10.21037/tcr-22-1746
https://doi.org/10.21037/tcr-22-1746
Autor:
Jixin Yang, Yuqing Yang, Xinxin Wen, Jiang Wu, Jing Yu, Lei Wang, Meiling Huang, Wenyu Hu, Wen Ma, Nanlin Li
Publikováno v:
Journal of Clinical Oncology. 40:e12622-e12622
e12622 Background: Despite that AC-THP regimen is one of the commonly used regimens for neoadjuvant treatment of HER2-positive breast cancer, previous studies showed that pCR rate rarely exceeds 70%. We hypothesized that prolonged dual anti-HER2 ther
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b385875843d5d796cd731a248abf29f
https://doi.org/10.1200/jco.2022.40.16_suppl.e12622
https://doi.org/10.1200/jco.2022.40.16_suppl.e12622
Background: Breast cancer is the most common cancer diagnosed among women and is the second leading cause of cancer death. It is of great significance to explore potential candidate targets. Methods: Cell function assays, siRNA, western blot, mass sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b6dad9efe4afd19878c76f7fa7889bd
https://doi.org/10.21203/rs.3.rs-272641/v1
https://doi.org/10.21203/rs.3.rs-272641/v1
Autor:
Guanghe, Bao, Huijun, Liu, Yanshou, Ma, Nanlin, Li, Fengquan, Lv, Xiangyuan, Dong, Xianxia, Chen
Publikováno v:
Am J Transl Res
To study the clinical efficacy and safety of different biliary drainages in malignant obstructive jaundice (MOJ) treatment. Methods: 69 patients with MOJ admitted to our hospital from October 2016 to March 2019 were recruited as the study cohort and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ed833ae117152759a9ed7fb6d21394af
https://pubmed.ncbi.nlm.nih.gov/34306512
https://pubmed.ncbi.nlm.nih.gov/34306512